Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06734611

Folic Acid Salt Study (FISFA Zambia)

Effectiveness Study of Folic Acid Fortified Iodized Salt to Increase Folate Concentrations in Women of Reproductive Age in Zambia, a Non-fortifying Country

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Question: How effective is fortified iodized salt with folic acid (FISFA) in increasing serum and red blood cell folate in non-lactating, non-pregnant women of reproductive age in the country of Zambia who do not have active food fortification with a folic acid program? Participants will: * Consume salt with folic acid instead of their regular salt for 6 months * Have a blood draw 4 times * Fill out surveys

Detailed description

The objective of this nonrandomized controlled intervention trial is to measure the effectiveness of fortified iodized salt with folic acid (FISFA) on increasing blood folate concentrations as a preventive measure against folate-sensitive neural tube defects (NTDs) in a non-fortifying country of Zambia. The main questions it aims to answer are: Aim 1: Measure the effectiveness of FISFA on increasing serum and red blood cell folate concentrations in women of reproductive age in a non-fortifying country. Aim 2: Assess the risk of neural tube defects by measuring folate insufficiency levels via serum and red blood cell concentrations in women of reproductive age in a non-fortifying country. Aim 3: Assess taste and color acceptability of FISFA by study population.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFortified Iodized Salt with Folic Acid (FISFA)Addition of folic acid to iodized salt for daily consumption to assess folate levels.

Timeline

Start date
2026-05-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2024-12-16
Last updated
2026-03-11

Locations

2 sites across 2 countries: United States, Zambia

Source: ClinicalTrials.gov record NCT06734611. Inclusion in this directory is not an endorsement.